INS and type 2 diabetes mellitus: In a 4-month double-blind, placebo-controlled study involving 40 patients with T2D, who were treated with metformin showed no differences in body weight, body fat, and fasting plasma insulin but reduced glycated hemoglobin (HbA1c) and fasting plasma glucose.